Analysis and Commentary STEVEN GROSSMAN 6/4/21 Analysis and Commentary STEVEN GROSSMAN 6/4/21 President's Budget Request Confirmed for FY 22 Read More Analysis and Commentary STEVEN GROSSMAN 5/28/21 Analysis and Commentary STEVEN GROSSMAN 5/28/21 President to Release FY 22 Budget Request Today Read More Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Analysis and Commentary STEVEN GROSSMAN 5/21/21 Analysis and Commentary STEVEN GROSSMAN 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Analysis and Commentary STEVEN GROSSMAN 4/23/21 Analysis and Commentary STEVEN GROSSMAN 4/23/21 Alliance "Hill Day": April 28 and 29 Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More Analysis and Commentary STEVEN GROSSMAN 3/6/21 Analysis and Commentary STEVEN GROSSMAN 3/6/21 Critical Supply Chains and the FDA Read More Analysis and Commentary STEVEN GROSSMAN 2/27/21 Analysis and Commentary STEVEN GROSSMAN 2/27/21 Questions (and Answers) About Current Political Issues Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Analysis and Commentary STEVEN GROSSMAN 1/29/21 Analysis and Commentary STEVEN GROSSMAN 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More Analysis and Commentary STEVEN GROSSMAN 1/16/21 Analysis and Commentary STEVEN GROSSMAN 1/16/21 Supporting a Budget Increase for FDA for FY 22 Read More Older Posts
Analysis and Commentary STEVEN GROSSMAN 6/4/21 Analysis and Commentary STEVEN GROSSMAN 6/4/21 President's Budget Request Confirmed for FY 22 Read More
Analysis and Commentary STEVEN GROSSMAN 5/28/21 Analysis and Commentary STEVEN GROSSMAN 5/28/21 President to Release FY 22 Budget Request Today Read More
Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Analysis and Commentary STEVEN GROSSMAN 5/21/21 Analysis and Commentary STEVEN GROSSMAN 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Analysis and Commentary STEVEN GROSSMAN 4/23/21 Analysis and Commentary STEVEN GROSSMAN 4/23/21 Alliance "Hill Day": April 28 and 29 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More
Analysis and Commentary STEVEN GROSSMAN 3/6/21 Analysis and Commentary STEVEN GROSSMAN 3/6/21 Critical Supply Chains and the FDA Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/21 Analysis and Commentary STEVEN GROSSMAN 2/27/21 Questions (and Answers) About Current Political Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More
Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
Analysis and Commentary STEVEN GROSSMAN 1/29/21 Analysis and Commentary STEVEN GROSSMAN 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More
Analysis and Commentary STEVEN GROSSMAN 1/16/21 Analysis and Commentary STEVEN GROSSMAN 1/16/21 Supporting a Budget Increase for FDA for FY 22 Read More
